contextualising the study by Peterson et al. [2], who present a valuable analysis of peri-operative risk during the initial months of the SARS-CoV-2 pandemic. Karlsson et al. [1] suggest applying existing management strategies used for children with symptomatic viral infection to those with confirmed SARS-CoV-2; using SARS-CoV-2 data to inform responses in future pandemics, and moving beyond data collection for children with SARS-CoV-2 undergoing general anaesthesia. We would like to add some alternative perspectives to some of these conclusions. We agree that the published evidence and anecdotal experience suggest the current risk of peri-operative respiratory adverse events in children with non-severe SARS-CoV-2 is similar to the risk with symptomatic viral upper respiratory tract infection [2, 3]. Therefore, we agree that current management of children with non-severe SARS-CoV-2 who present for anaesthesia should be consistent with established practice with other symptomatic viral upper respiratory tract infections. This may include discontinuation of universal pre-operative testing for SARS-CoV-2 and replacement with symptoms or history-based assessment, as has already occurred in many hospitals.